Prescriber Update - Medsafe
NEW ZEALAND MEDICINES AND MEDICAL DEVICES SAFETY AUTHORITY A BUSINESS UNIT OF THE MINISTRY OF HEALTH www.medsafe.govt.nz Prescriber Update Vol. 31 No. 2
Download Prescriber Update - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Public Assessment Report - GOV.UK
www.mhra.gov.ukPAR Tetmodis 25mg tablets UK/H/1816/001/DC Module 1 Product Name Tetmodis 25mg tablets Type of Application Generic application, Article 10.1
MODERATE SEDATION MODULE - EduTracker
edutracker.comModerate Sedation/Analgesia (Formerly referred to as “ onscious Sedation”) is a drug-induced depression of con- sciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tac-
Pediatric & Adult Moderate Sedation - Clinical …
www.clinicalsolutionsme.com1. Complete the moderate sedation module self-study packet. 2. Attend the moderate sedation workshop (one-time mandatory class) 3. Complete moderate sedation initial competence checklist for employee
Pain Management and Dosing Guide - American …
americanpainsociety.orgPain Management and Dosing Guide Includes: 1. Principles of Pain Management, Discharge and Patient Safety Considerations, Analgesic Ladder 2.
THE AMERICAN BOARD OF SURGERY
www.absurgery.orgTHE AMERICAN BOARD OF SURGERY FLEXIBLE ENDOSCOPY CURRICULUM FOR GENERAL SURGERY RESIDENTS Table of Contents (click to go to section) ABS Flexible Endoscopy Curriculum ...